Evidence map›Paper›PMID 40531712›Full record

ArticleEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2025

Impact of COVID-19 on the incidence of visceral leishmaniasis in children and adolescents in the Northeast region, 2007-2022: time series study.

Pedro Henrique Ferreira Dos Santos, Bruna Rykelly Ramos Dos Santos, Karol Fireman de Farias

Abstract read
In one paragraph

Article in Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pedro Henrique Ferreira Dos SantosUniversidade Federal de Alagoas, Arapiraca, AL, Brazil.ORCID http://orcid.org/0000-0003-2105-8095
Bruna Rykelly Ramos Dos SantosUniversidade Federal de Alagoas, Arapiraca, AL, Brazil.ORCID http://orcid.org/0000-0002-7240-0420
Karol Fireman de FariasUniversidade Federal de Alagoas, Arapiraca, AL, Brazil.ORCID http://orcid.org/0000-0003-1352-2513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the impact of COVID-19 on the incidence of visceral leishmaniasis in children and adolescents living in the Northeast region of Brazil.

methodsTime series study with data from the Notifiable Diseases Information System, from the study of population estimates by municipality, age and sex from 2000 to 2021, and from the Brazilian Institute of Geography and Statistics. An analysis of the temporal trends of the incidence rate was performed using the Joinpoint software, calculating the average annual percentage variation (AAPV) and its 95% confidence intervals (95%CI). The percentage variation in incidence rates from 2020 to 2022 was also calculated to check whether they were below or above what was expected for the year and territory.

resultsFrom 2007 to 2022, 13,890 new cases of visceral leishmaniasis were reported in children and adolescents in Northeast Brazil. Changes in trends were identified with the addition of the years of the COVID-19 pandemic, from 2020 to 2022, in the Northeast: AAPV (2007-2019) 0.44; 95%CI -2.23; 3.18; AAPV (2007-2022) -7.95; 95%CI -13.63; -1.88), Pernambuco: AAPV (2007-2019) 6.77; 95%CI 2.04; 11.71; AAPV (2007-2022) -1.40; 95%CI -8.75; 6.53 and Alagoas: AAPV (2007-2019) 11.51; 95%CI 4.90; 18.53; AAPV (2007-2022) -1.33; 95%CI -14.89; 14.40).

conclusionThe Northeast and its states where changes in temporal trends were observed after the COVID-19 pandemic are priorities for the intensification of actions to combat and control the disease.

Indexed as

COVID-19Leishmaniasis, VisceralAdolescentBrazilChildChild, PreschoolFemaleHumansIncidenceInfantMaleTime Factors

Identifiers

PMID40531712
PMCPMC12176430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.